All In MedTech

Device Trial Radar · NCT02379273

Nucleus Hybrid L24 Extended Duration Post Approval Study

The Nucleus Hybrid L24 Implant System: Extended Duration Post Approval Study

Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

35

Actual

Start

Jan 14, 2015

Primary completion

Mar 18, 2019

Study completion Mar 18, 2019

Sponsor

Lead sponsor
CochlearNot on our public-company list
Sponsor type
Industry
Collaborators
University of Iowa; NYU Langone Health; Midwest Ear Institute; University of Cincinnati; Ohio State University; Mayo Clinic; Hearts for Hearing
First posted
Mar 4, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post approval study evaluates the long term safety and efficacy of the Nucleus Hybrid L24 Implant System in a group of already implanted recipients.

Conditions

  • Hearing Loss

Interventions

  • Nucleus Hybrid L24 ImplantDevice

    Subjects have already been implanted with the Nucleus Hybrid L24 implant.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Consonant-Nucleus-Consonant (CNC) Word Recognition in Quiet: Percentage of Total Words Correctly Recognized.Time frame: 5 years postactivation.
  2. AzBio (Arizona Biomedical Institute) Sentence Recognition in Noise: Percentage of Total Words Correctly Recognized.Time frame: 5 years postactivation.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.